Multivariate analysis of prognostic factors
| . | P . | HR . | 95% CI . |
|---|---|---|---|
| 3-year LFS (n = 543) | |||
| Age at transplantation > 47 y | .92 | 0.99 | 0.77-1.27 |
| CD34+ > 7.16 × 106/kg | .027 | 0.73 | 0.55-0.96 |
| WBC at diagnosis > 15 × 109/kg | .18 | 0.84 | 0.65-1.08 |
| Good cytogenetics versus other | < .001 | 2.86 | 1.79-4.55 |
| No. of induction courses > 1 | < .001 | 0.50 | 0.36-0.68 |
| No. of consolidation courses to collection ≥ 2 | .64 | 1.06 | 0.83-1.37 |
| TBI | .25 | 1.28 | 0.84-1.96 |
| Center | .3 | ||
| 3-year relapse (n = 543) | |||
| Age at transplantation > 47 y | .67 | 0.94 | 0.72-1.23 |
| CD34+ > 7.16 × 106/kg | .013 | 1.46 | 1.08-1.98 |
| WBC at diagnosis > 15 × 109/kg | .22 | 1.19 | 0.9-1.56 |
| Good cytogenetics versus other | < .001 | 0.35 | 0.21-0.58 |
| No. of induction courses > 1 | < .001 | 1.96 | 1.37-2.79 |
| No. of consolidation courses to collection ≥ 2 | .16 | 0.82 | 0.63-1.08 |
| TBI | .53 | 0.87 | 0.57-1.34 |
| Center | .91 | ||
| 3-year NRM | |||
| Age at transplantation > 47 y | .22 | 1.49 | 0.79-2.82 |
| CD34+ > 7.16 × 106/kg | .79 | 0.9 | 0.39-2.03 |
| WBC at diagnosis > 15 × 109/kg | .66 | 1.15 | 0.62-2.14 |
| Good cytogenetics versus other | .1 | 0.36 | 0.11-1.19 |
| No. of induction courses > 1 | .03 | 2.27 | 1.07-4.82 |
| No. of consolidation courses to collection ≥ 2 | .04 | 1.96 | 1.02-3.77 |
| TBI | .14 | 0.22 | 0.03-1.64 |
| Center | .2 |
| . | P . | HR . | 95% CI . |
|---|---|---|---|
| 3-year LFS (n = 543) | |||
| Age at transplantation > 47 y | .92 | 0.99 | 0.77-1.27 |
| CD34+ > 7.16 × 106/kg | .027 | 0.73 | 0.55-0.96 |
| WBC at diagnosis > 15 × 109/kg | .18 | 0.84 | 0.65-1.08 |
| Good cytogenetics versus other | < .001 | 2.86 | 1.79-4.55 |
| No. of induction courses > 1 | < .001 | 0.50 | 0.36-0.68 |
| No. of consolidation courses to collection ≥ 2 | .64 | 1.06 | 0.83-1.37 |
| TBI | .25 | 1.28 | 0.84-1.96 |
| Center | .3 | ||
| 3-year relapse (n = 543) | |||
| Age at transplantation > 47 y | .67 | 0.94 | 0.72-1.23 |
| CD34+ > 7.16 × 106/kg | .013 | 1.46 | 1.08-1.98 |
| WBC at diagnosis > 15 × 109/kg | .22 | 1.19 | 0.9-1.56 |
| Good cytogenetics versus other | < .001 | 0.35 | 0.21-0.58 |
| No. of induction courses > 1 | < .001 | 1.96 | 1.37-2.79 |
| No. of consolidation courses to collection ≥ 2 | .16 | 0.82 | 0.63-1.08 |
| TBI | .53 | 0.87 | 0.57-1.34 |
| Center | .91 | ||
| 3-year NRM | |||
| Age at transplantation > 47 y | .22 | 1.49 | 0.79-2.82 |
| CD34+ > 7.16 × 106/kg | .79 | 0.9 | 0.39-2.03 |
| WBC at diagnosis > 15 × 109/kg | .66 | 1.15 | 0.62-2.14 |
| Good cytogenetics versus other | .1 | 0.36 | 0.11-1.19 |
| No. of induction courses > 1 | .03 | 2.27 | 1.07-4.82 |
| No. of consolidation courses to collection ≥ 2 | .04 | 1.96 | 1.02-3.77 |
| TBI | .14 | 0.22 | 0.03-1.64 |
| Center | .2 |
LFS indicates leukemia-free survival; HR, hazard ratio; CI, confidence interval; WBC, white blood cell count; TBI, total body irradiation; and NRM, nonrelapse mortality.